Issuance of Stock Options Through the 9th and 10th Series Share Acquisition Rights
First written in FY2025-Q1. 1 of 3 entries say "Restated". Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Ninth Series of Stock Acquisition Rights: Vested 57,700; Exercised —; Forfeited —; Unvested balance 81,900」
Stock acquisition rights covering 57,700 shares under the Ninth Series vested, while rights covering 81,900 shares remained unvested. - FY2025RestatedAnnual report
「The estimation method for the fair value per unit of the Ninth and Tenth Series of Stock Options granted during the consolidated fiscal year is as follows.」
The company disclosed in its annual report the terms of the Ninth and Tenth Series of Stock Acquisition Rights, covering 152,000 common shares with an exercise period from 29 June 2026 to 29 May 2034, and recorded ¥17.225 million in share-based compensation expense during the fiscal year. - FY2025-Q1First statedAnnual report
「1. Ninth Series of Stock Acquisition Rights: At a meeting of its Board of Directors held on 29 May 2024, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the Ninth Series of Stock Acquisition Rights as stock options to its directors, including outside directors, and employees, and issued them on 28 June 2024. 2. Tenth Series of Stock Acquisition Rights: At a meeting of its Board of Directors held on 29 May 2024, the company resolved, pursuant to Articles 236, 238 and 239 of the Companies Act, to issue the Tenth Series of Stock Acquisition Rights as stock options to external collaborators, and issued them on 28 June 2024.」
The Ninth Series of Stock Acquisition Rights was granted to 4 directors and 106 employees, covering 152,000 shares, while the Tenth Series was granted to 1 external collaborator, covering 500 shares. The exercise price is ¥660 per share for both series, and the exercise period runs from 29 June 2026 to 29 May 2034.